X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Statistics in Biopharmaceutical Research

期刊標題檢索 STAT BIOPHARM R 最新評論: Review Speed: 1.0 | Submission Acceptance Rate: 25.0 Experience Sh... (2024-05-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Statistics in Biopharmaceutical Research]您好,您是該頁面的第 13430 位訪客。

期刊簡介
期刊名稱Statistics in Biopharmaceutical Research Statistics in Biopharmaceutical Research
LetPub Score
4.9
50 ratings
Rate

Reputation
6.1

Influence
3.5

Speed
7.3

期刊簡稱STAT BIOPHARM RES
ISSN1946-6315
h-index11
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.900.9780.915
Subject fieldQuartilesRankPercentile
Category: Mathematics
Subcategory: Statistics and Probability
Q149 / 278
Category: Mathematics
Subcategory: Pharmaceutical Science
Q284 / 183

自引率 (2023-2024)26.70%自引率趨勢
掲載範囲
Statistics in Biopharmaceutical Research ( SBR), publishes articles that focus on the needs of researchers and applied statisticians in biopharmaceutical industries; academic biostatisticians from schools of medicine, veterinary medicine, public health, and pharmacy; statisticians and quantitative analysts working in regulatory agencies (e.g., U.S. Food and Drug Administration and its counterpart in other countries); statisticians with an interest in adopting methodology presented in this journal to their own fields; and nonstatisticians with an interest in applying statistical methods to biopharmaceutical problems.

Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of statistics in all phases of research, development, and practice in the pharmaceutical, biopharmaceutical, device, and diagnostics industries. Articles should focus on the development of novel statistical methods, novel applications of current methods, or the innovative application of statistical principles that can be used by statistical practitioners in these disciplines. Areas of application may include statistical methods for drug discovery, including papers that address issues of multiplicity, sequential trials, adaptive designs, etc.; preclinical and clinical studies; genomics and proteomics; bioassay; biomarkers and surrogate markers; models and analyses of drug history, including pharmacoeconomics, product life cycle, detection of adverse events in clinical studies, and postmarketing risk assessment; regulatory guidelines, including issues of standardization of terminology (e.g., CDISC), tolerance and specification limits related to pharmaceutical practice, and novel methods of drug approval; and detection of adverse events in clinical and toxicological studies. Tutorial articles also are welcome. Articles should include demonstrable evidence of the usefulness of this methodology (presumably by means of an application).

The Editorial Board of SBR intends to ensure that the journal continually provides important, useful, and timely information. To accomplish this, the board strives to attract outstanding articles by seeing that each submission receives a careful, thorough, and prompt review.

Authors can choose to publish gold open access in this journal.
官方網站https://www.tandfonline.com/journals/usbr20
在線稿件提交https://mc.manuscriptcentral.com/amstat
開放訪問Yes (Hybrid OA journal)
出版商Taylor and Francis Ltd.
主題領域MATHEMATICAL & COMPUTATIONAL BIOLOGY
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年2009
每年文章數53每年文章數趨勢
黃金OA百分比14.02%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MATHEMATICAL & COMPUTATIONAL BIOLOGYSCIEQ346/65
STATISTICS & PROBABILITYSCIEQ243/168
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1946-6315%5BISSN%5D
平均審稿時間 *來自出版商的數據: Submission to first decision: 65 days; Submission to first post-review decision: 101 days; Acceptance to online publication: 48 days;
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: 41%
參考鏈接
相關期刊 【Statistics in Biopharmaceutical Research】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Annual Review of Statistics and Its ApplicationH-index: 18

    CiteScore: 13.40
    R JournalH-index: 28

    CiteScore: 2.70
    Scandinavian Actuarial JournalH-index: 32

    CiteScore: 3.30
    LAW PROBABILITY & RISKH-index: 11

    CiteScore: 2.10
    Quality EngineeringH-index: 36

    CiteScore: 3.90
    ExtremesH-index: 29

    CiteScore: 2.20
    ECONOMETRIC THEORYH-index: 61

    CiteScore: 1.90
    International Journal of BiostatisticsH-index: 28

    CiteScore: 2.30
    Stochastics-An International Journal of Probability and Stochastic ProcessesH-index: 18

    CiteScore: 1.90
    學科內最受檢索的期刊 頁面查看次數
    R Journal32631
    Quality Engineering25824
    Stochastics-An International Journal of Probability and Stochastic Processes22781
    ECONOMETRIC THEORY19355
    Scandinavian Actuarial Journal18756
    Annual Review of Statistics and Its Application17884
    Extremes16856
    International Journal of Biostatistics12193
    LAW PROBABILITY & RISK9429
  •  

    Statistics in Biopharmaceutical Research Statistics in Biopharmaceutical Research
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Statistics in Biopharmaceutical Research] 的評論撰寫評論
作者: 宗室志涛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-17 12:24:22 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 25.0
Experience Sharing: Both articles submitted with a statistical approach were directly rejected without even being sent for review
(0) 讚! | 宗室志涛

作者: 笑忘书


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-26 10:49:19 評論於
The official website of this journal provides two submission URLs. The first one, https://mc.manuscriptcentral.com/amstat, is the general submission portal of the American Statistical Association (not a specific journal). In this portal, you need to choose a specific journal from the dropdown menu in the first column. Please note that this is not the submission URL for another journal, despite the similar appearance.

Additionally, there is another submission portal by Taylor, and it is unclear if the manuscript statuses are interconnected between the two portals. The URL for Taylor's submission portal is https://rp.tandfonline.com/submission/create?journalCode=USBR.
(3) 讚! | 笑忘书

作者: Jack


領域: 数理科学
審稿時間: 6.0 month(s)
結果: 修改後接受


撰寫評論

2017-10-02 13:49:06 評論於
Okay.
(1) 讚! | Jack

作者: 北岳山阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-10-02 08:41:19 評論於
Review speed: 6.0 Experience sharing: Not bad
(0) 讚! | 北岳山阳

作者: Yves Morton


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-02 11:29:47 評論於
Review speed: 1.0 | Submission acceptance rate: 75.0
Experience Sharing: A pretty bad journal, the review speed is unusually slow
(0) 讚! | Yves Morton

作者: 66


領域: 数理科学
審稿時間: 12.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-02 07:44:12 評論於
A fairly poor journal, the speed of review is not generally slow.
(3) 讚! | 66

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Statistics in Biopharmaceutical Research] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*